Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CVS HEALTH Corp Director's Dealing 2021

Jun 8, 2021

29875_dirs_2021-06-08_429ed930-0763-4a76-a38d-b1f69dde8572.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CVS HEALTH Corp (CVS)
CIK: 0000064803
Period of Report: 2021-06-07

Reporting Person: Finke Daniel P (EVP/Pres, Health Care Benefits)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-06-07 Common Stock M 32320 $54.19 Acquired 60903.5841 Direct
2021-06-07 Common Stock S 37594 $86.60 Disposed 23309.5841 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-06-07 Stock Option $54.19 M 32320 Disposed 2029-04-01 Common Stock (32320) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock (pep) 3041.5841 Direct
Common Stock (restricted) 25701 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option $58.34 2030-04-01 Common Stock (54332) 54332 Direct
Stock Option $74.30 2031-04-01 Common Stock (82066) 82066 Direct
Stock Option $52.37 2029-05-31 Common Stock (28640) 28640 Direct

Footnotes

F1: All sales were effected pursuant to a Rule 10b5-1 plan.

F2: Represents weighted average sale price for this group of sales, which occurred on the same trading day. Multiple sales were executed, with sales prices ranging from $86.52 and $86.71 per share.

F3: Option became exercisable in four equal annual installments, beginning on 4/1/2020.

F4: Option became exercisable in four equal annual installments, commencing 4/1/2021.

F5: Option becomes exercisable in four equal installments, commencing 4/1/2022.

F6: Option becomes exercisable in three equal installments, commencing 5/31/2022.